UroGen Pharma Ltd. (URGN)
NASDAQ·Healthcare·Biotechnology
$42.50
+0.62%
Mkt Cap $2.15B
Analyst Ratings
Buy
10
Hold
0
Sell
0
Price Target (15 analysts)
$44.20
Range $40.00 – $50.00
Implied Upside
+4.0%
Consensus $44.20 vs current $42.50
NASDAQ·Healthcare·Biotechnology
$42.50
+0.62%
Mkt Cap $2.15B
Buy
10
Hold
0
Sell
0
Price Target (15 analysts)
$44.20
Range $40.00 – $50.00
+4.0%
Consensus $44.20 vs current $42.50